Brainstorm Cell Therapeutics shares owned by Morgan Stanley
Quarter-by-quarter ownership of Brainstorm Cell Therapeutics (BCLI) shares owned by Morgan Stanley
from 13F filings
Historical chart of Morgan Stanley investment in Brainstorm Cell Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Brainstorm Cell Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Brainstorm Cell Therapeutics by Morgan Stanley
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-06-30 | $6.5k | 5.8k | 1.12 |
| 2024-12-31 | $9.8k | 4.3k | 2.27 |